West Africa Gold Mining Chemicals Market Primed to Hit $14.6 Million by 2030

 West Africa Gold Mining Chemicals Market Growth & Trends

The West Africa gold mining chemicals market size is expected to reach USD 14.6 million by 2030 to expand at a CAGR of 7.3% from 2023 to 2030 as per the new report by Grand View Research, Inc. This is attributed to increasing gold mining activities in African countries. West Africa is a significant contributor of gold, iron ore, uranium, and diamonds through its extraction activities. In addition to these valuable minerals, the region possesses abundant reserves of aluminum, nickel, phosphate, manganese, and zinc. Despite the considerable mineral wealth, a large portion of it has yet to be exploited, suggesting that West Africa's role in the worldwide mineral economy will become more prominent in the years to come.

Additionally, the rising demand for different minerals across regions has resulted in the hike in mine activities, thus, is likely to boost the market over the forecast period. The demand for gold is increasing every year in India, China, the U.S., Saudi Arabia, the UAE, Turkey, Russia, and Egypt being its leading consumer. As of 2021, according to Outlook Publishing India Pvt. Ltd., India and China together account for more than 57% of the total consumption of gold globally.

Furthermore acid mine drainage is one of the major problems for water sources. Mines with acid drainage can have a long-lasting impact on rivers and aquatic life. Mineral deposits containing sulfides, such as zinc, silver, lead, gold, coal, copper, and aluminum, when mined may lead to the creation of acid mine drainage. These minerals, when exposed to water and oxygen result in the formation of sulfuric acid. Acid mine drainage has the potential to decrease water quality by lowering the pH and dissolved metal content of groundwater. Besides, the mining processes adversely affect the wildlife. Mining results in the contamination of soil, as well as water, thereby affecting the wild and marine animals. Moreover, the leakage of hazardous materials into the environment can also have a significant impact on human health. These factors are likely to restrain the growth over the predicted period.

Request a free sample copy or view report summary: West Africa Gold Mining Chemicals Market Report

West Africa Gold Mining Chemicals Market Report Highlights

• The lubricantsproduct segment witnessed the fastest CAGR of 9.2%. This is attributed to the fact that gold can be used as a lubricant in numerous engineering applications, depending on its resistance to cold welding
• The water treatment application segment witnessed the fastest growth rate with a CAGR of 7.5%. This is attributed to the demand for water treatment in the mining industry has been witnessing considerable growth on account of rising concerns regarding the release of mining pollutants to natural water sources and the highly acidic nature of the mining water
• Mali witnessed the fastest growth rate with a CAGR of 8.1% in 2022. This growth is attributed to the fact that Mali is the fourth-largest producer of gold in Africa, according to International Trade Administration (ITA)
• In September 2020, Clariant signed a distribution agreement with ChemQuest to distribute its specialty chemicals to mining companies in South Africa, Zambia, DRC, and Zimbabwe

Access Press Release@ https://www.grandviewresearch.com/press-release/west-africa-gold-mining-chemicals-market-analysis

West Africa Gold Mining Chemicals Market Segmentation

Grand View Research has segmented the West Africa gold mining chemicals market based on product, application and country:

West Africa Gold Mining Chemicals Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Collectors
• Coatings
• Flocculants
• Grinding Aids
• Solvent Extractants
• Dust Suppressants
• Defoamers
• Antiscalants
• Biocides
• Lubricants
• Frothers
• Others

West Africa Gold Mining Chemicals Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Mineral Processing
• Explosives and Drilling
• Water Treatment
• Others

West Africa Gold Mining Chemicals Country Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Burkina Faso
• Ivory Coast
• Mali
• Niger
• Ghana

List of Key Players in the West Africa Gold Mining Chemicals Market

• AECI Mining Chemicals
• Arkema
• Akzo Nobel N.V.
• Ashland
• BASF SE
• Clariant
• Cytec Solvay Group
• Dow
• Kemira
• Kimleigh Chemicals SA (Pty) Ltd.
• Nowata
• Quaker Chemical Corporation
• Sasol
• Shell Chemicals
• Solenis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Indonesia Business Process Outsourcing Market Factors, Rising Demand, Driving Growth by 2030

 Indonesia Business Process Outsourcing (BPO) Market Growth & Trends

The Indonesia business process outsourcing market size is expected to reach USD 3.94 billion by 2030, expanding at a CAGR of 10.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the shifting focus of end-user organizations on outsourcing which enable them to concentrate on core capabilities and high adoption of cloud computing due to low maintenance costs, & high operational efficiency. By using cloud-based business process outsourcing (BPO) services, businesses can avoid significant upfront expenditures as cloud service providers manage these resources at nominal costs, driving the growth of the market. In many cases, organizations must adopt BPO solutions due to the additional financial flexibility and savings it offers, creating a favorable environment for the market.

The key players in Indonesia's business process outsourcing industry have been involved in strategic initiatives to get more traction in the market. For instance, in January 2021, a subsidiary of VADS, VADS Indonesia, along with TM ONE, signed an agreement with FNS Value Co., Limited, which offers Blockchain Secure Authentication solutions. As per the agreement, VADS is the sole distributor of Blockchain Secure Authentication (BSA) solutions in the Indonesia, Malaysia, and ASEAN regions offered by FNSV.

Furthermore, in June 2022, a digital telecommunication company in Indonesia, Indosat Ooredoo Hutchison, partnered with AI-based cloud solution provider VOXOX to bring Cloud-Voice, an SMS and voice automation solution, to empower small businesses in Indonesia. This solution will allow its clients to automate time-consuming text, voice, and other sales & customer engagement tasks, helping them to focus on providing customer-centric extraordinary services.

Indonesia's business process outsourcing industry has also notably benefitted from the various measures taken and regulations developed by the Indonesian government to help attract investment and drive the growth of the Indonesia BPO industry. For instance, in March 2023, the Indonesian parliament passed an emergency decree on investment and jobs into law, replacing the 2020 Jobs Creation Law. The new law is aimed at spurring business sentiment in the country and is expected to open vast growth opportunities for the Indonesia BPO industry. The geographic proximity of Indonesia to BPO powerhouses such as the Philippines and India could also help attract customers in the Indonesia business process outsourcing industry.

Request a free sample copy or view report summary: Indonesia Business Process Outsourcing (BPO) Market Report

Indonesia Business Process Outsourcing (BPO) Market Report Highlights

• The customer services segment is expected to register a CAGR of 11.3% from 2023 to 2030. The shifting focus of companies on improving their consumer experience to increase customer retention rate and attract potential audiences is driving the growth of the customer services segment
• The BFSI segment is anticipated to grow at a CAGR of 10.9% from 2023 to 2030. Financial institutions and banks are adopting business process outsourcing services for various BFSI domains, such as asset management & investment management, to improve their cost efficiency
• The Indonesia BPO industry has witnessed the entry of several players offering cloud-based BPO services, some of which are among the top companies in the world. For instance, NTT DATA Indonesia launched a cloud-based digital platform & partner ecosystem, Global Insurance Digital Platform (GIDP), which offers Business Process as a Service (BPaaS), third-party administration, partnership, and consulting

Access Press Release@ https://www.grandviewresearch.com/press-release/indonesia-business-process-outsourcing-market-analysis

Indonesia Business Process Outsourcing (BPO) Market Segmentation

Grand View Research has segmented the Indonesia business process outsourcing market based on service type and end-use:

Indonesia Business Process Outsourcing (BPO) Service Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Finance & Accounting
• Human Resource
• KPO
• Procurement & Supply Chain
• Customer Services
• Others (Legal & tax, Logistics, and Training)

Indonesia Business Process Outsourcing (BPO) End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• BFSI
• Healthcare
• Manufacturing
• IT & Telecommunications
• Retail
• Others (Construction & Utilities, Travel & Transportation, and Government & Education)

List of Key Players in the Indonesia Business Process Outsourcing (BPO) Market

• Concentrix Corporation
• Conduent, Inc.
• ExlService Holdings, Inc.
• Foundever
• Genpact
• KPSG
• Majorel
• Relia, Inc.
• Teleperformance
• TELUS
• Transcom
• Transcosmos inc.
• TTEC Holdings, Inc.
• VADS BERHAD
• WNS (Holdings) Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Gummy Market to Reflect a Holistic Expansion During 2024 to 2030: Grand View Research Inc.

Gummy Market Growth & Trends

The global gummy market size is expected to reach USD 52.24 billion by 2030, registering a CAGR of 11.8% over the forecast period, according to a new report by Grand View Research, Inc. The demand for the gummies is anticipated to be driven by several factors such as the rising consumer awareness of the negative side effects of excessive chocolate consumption, advancements in manufacturing technologies, and growing consumer demand for natural products as well as a growing interest in vegan gummies.

The rising consumer awareness of the negative side effects of excessive chocolate consumption, such as weight gain and dental problems, is contributing to the growth of the gummies market. As consumers become more health-conscious, they are turning to gummies as a healthier alternative to traditional chocolate candy. In addition, the sugar content of gummies can also be a driving factor. While many gummies’ products do contain sugar, there is also a growing demand for sugar-free and low-sugar options. Manufacturers are responding to this trend by introducing gummies products that use natural sweeteners, such as stevia or monk fruit, instead of traditional sugar.

The rising awareness of veganism and the introduction of vegan gummies, along with brand campaigns by supplement manufacturers, have contributed to the growth of the adult gummies market. These gummies are made without animal-based ingredients and are suitable for individuals following a vegan diet. With the growing demand for vegan products, the introduction of vegan gummies has helped to expand the market and reach a wider audience of health-conscious adults who follow a plant-based lifestyle. In January 2022, Vegums, a UK-based vegan gummy supplement brand, expanded its business to the U.S. market with the launch of three products: a multivitamin, omega 3, and iron. The company aims to tap into the growing demand for vegan-friendly supplements and provide a convenient and tasty alternative to traditional pills.

Supplements in the form of gummies are a relatively new and innovative product in the supplement industry, and their unique texture and taste are driving their popularity among consumers looking for something new and different. Gummy supplements are similar to candies and are enriched with nutrients. Gummy supplements are often made with natural fruit flavors and sweeteners, which can make them more palatable than traditional capsules or tablets. They are more appealing to children and adults who have difficulty swallowing pills. These were initially formulated for adults unwilling to take pills and later became popular among other groups as well because of their visual appeal and easy digestion.

Manufacturers are expanding their product lines through product launches, mergers, and acquisitions to meet the growing demand for gummies for specific health benefits. For instance, manufacturers are launching new gummies driven by increasing consumer awareness regarding gut and immune health. In January 2022, Pantheryx launched sugar-free probiotic gummies for children and adults in its TruBiotics line of supplements. The main functions of these probiotic gummies include gut-health support and ease of digestion through enzyme production.

Request a free sample copy or view report summary: Gummy Market Report

Gummy Market Report Highlights

• Based on products, vitamins dominated the market with a market share of 23.9% in 2023 owing to the increasing prevalence of vitamin deficiencies. Vitamin gummies have become popular among consumers as they are an easy and enjoyable way to supplement their daily nutrient intake
• Based on end-use, the market is segmented into adults, and kids. Adult consumers dominated the market with a revenue share of 66.3% in 2023 and it's expected to continue its dominance over the forecast period. The rising demand for gummy supplements among adults due to their potential health benefits drives market growth
• Based on distribution channel, the market is segmented into offline, and online channels. The offline distribution channel dominated the market with a market share of 81.2% in 2023. This was primarily due to the easy availability and wider reach of offline channels, which include supermarkets, convenience stores, and traditional retail stores. These channels offer consumers the convenience of in-person shopping and are often accessible to a wider range of consumers compared to online channels
• The North America region dominated the market with a revenue share of 37.42% in 2023 owing to the increasing demand for functional and fortified gummies, and innovation in gummy products.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-gummy-market

Gummy Market Segmentation

Grand View Research has segmented the global gummy market based on product, ingredient, end-use, distribution channel, and region:

Gummy Product Outlook (Revenue, USD Million, 2018 - 2030)

• Vitamins
• Minerals
• Carbohydrates
• Omega Fatty Acids
• Proteins & Amino Acids
• Probiotics & Prebiotics
• Dietary Fibers
• CBD/CBN
• Psilocybin/Psychedelic Mushroom
• Melatonin
• Others

Gummy Ingredient Outlook (Revenue, USD Million, 2018 - 2030)

• Gelatin
• Plant-based Gelatin substitutes

Gummy End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Adults
• Men
• Women
• Pregnant Women
• Geriatric
• Kids

Gummy Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Offline
  • Hypermarkets/Supermarkets
  • Pharmacies
  • Specialty Stores
  • Practitioner
  • Others
• Online

Gummy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • South Korea
• Central & South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • UAE

List of Key Players of Gummy Market

• Procaps Group
• Santa Cruz Nutritionals
• Amapharm
• Herbaland Canada
• Allseps Pty. Ltd.
• Vitux AS
• Boscogen, Inc.
• Bettera Brands, LLC
• NutraStar Manufacturing Ltd.
• Better Nutritionals
• Prime Health Ltd.
• AJES Pharmaceuticals LLC
• Lactonova
• com
• Lexicare Pharma Pvt. Ltd.
• Superior Supplement Manufacturing
• Well Aliments
• Supplement Factory Ltd.
• Vitakem Nutraceutical, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Post Laser Recovery Products Market Insights Business Opportunities, Current Trends And Forecast 2030: Grand View Research Inc.

 U.S. Post Laser Recovery Products Market Growth & Trends

The U.S. post-laser recovery products market size is expected to reach USD 293.0 million by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 9.9% during the forecast period. Post-laser recovery products help to promote the recovery of the skin after undergoing aesthetic procedures.

A post-laser recovery product is designed to help soothe the uncomfortable side effects after ablative and non-ablative laser procedures. Each product has been designed to help to prevent long-term inflammation and minimize pain, itch, and discomfort. The increasing prevalence of skin conditions is a significant factor leading to an increase in the demand for laser treatments which in turn is driving the growth of the post-laser recovery products market.

Immunosuppressed people are more likely to develop skin diseases than healthy people because they are more susceptible to bacterial, fungal, and other disease-causing organisms. Furthermore, a growing number of road accidents and burn cases is also anticipated to drive market growth. As per WHO, approximately 10 million people are disabled or injured due to road accidents every year, which frequently result in scars, requiring surgical treatment.

The market for post-laser recovery products has been severely impacted by the COVID-19 outbreak. The aesthetics industry witnessed significant setbacks due to the COVID-19 pandemic in the first and second quarters of 2020. Lockdowns caused the closure of beauty salons, med spas, dermatological clinics, and retail establishments in various nations because the procedures for cosmetic needs were not medically necessary. Worldwide, hospital management and government representatives asked medical staff to postpone non-emergency appointments. In addition, lockdowns around the world caused numerous retail businesses to close during the first quarter of 2020. Physical store sales were affected as a result.

Request a free sample copy or view report summary: U.S. Post Laser Recovery Products Market Report

U.S. Post Laser Recovery Products Market Report Highlights

• Based on product, cream segment dominated the market in 2022 owing to the higher recommendation of sunscreen and moisturizer for skin recovery, which is the major factor for segment dominance. As per the aesthetician using ceramide creams helps to restore the skin barrier that gets weakened after the laser treatments and also helps in skin regeneration for the skin to heal faster.
• Based on distribution channel, offline channel is dominating the market in 2022. This is due to the fact that a large number of patients still opt for offline distribution of post-laser recovery products as they believe in assessing comfort and finding the best fit for their clinical needs. However, the online segment is likely to have a significant growth rate during the forecast period.
• Key market players include; NeoGenesis, CALECIM Clinic, LA CLINICA, Synergie Skin, RAI Aesthetics, Bynacht, Koru Pharma, Elixir Cosmeceuticals, OxygenCeuticals, Gio Pelle, and Others

Access Press Release@ https://www.grandviewresearch.com/press-release/us-post-laser-recovery-products-market-analysis

U.S. Post Laser Recovery Products Market Segmentation

Grand View Research has segmented the U.S. post-laser recovery products market on the basis of product type, and distribution channel:

U.S. Post Laser Recovery Products Type Outlook (Revenue, USD Million, 2018 - 2030)

• Cream
• Gel
• Serum
• Others

U.S. Post Laser Recovery Products Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online
• Offline

List of Key Players of the U.S. Post Laser Recovery Products Market

• NeoGenesis
• CALECIM Clinic
• LA CLINICA
• Synergie Skin
• RAI Aesthetics
• Bynacht
• Koru Pharma
• Elixir Cosmeceuticals
• OxygenCeuticals
• Gio Pelle

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Post Laser Recovery Products Market Insights Business Opportunities, Current Trends And Forecast 2030: Grand View Research Inc.

 U.S. Post Laser Recovery Products Market Growth & Trends

The U.S. post-laser recovery products market size is expected to reach USD 293.0 million by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 9.9% during the forecast period. Post-laser recovery products help to promote the recovery of the skin after undergoing aesthetic procedures.

A post-laser recovery product is designed to help soothe the uncomfortable side effects after ablative and non-ablative laser procedures. Each product has been designed to help to prevent long-term inflammation and minimize pain, itch, and discomfort. The increasing prevalence of skin conditions is a significant factor leading to an increase in the demand for laser treatments which in turn is driving the growth of the post-laser recovery products market.

Immunosuppressed people are more likely to develop skin diseases than healthy people because they are more susceptible to bacterial, fungal, and other disease-causing organisms. Furthermore, a growing number of road accidents and burn cases is also anticipated to drive market growth. As per WHO, approximately 10 million people are disabled or injured due to road accidents every year, which frequently result in scars, requiring surgical treatment.

The market for post-laser recovery products has been severely impacted by the COVID-19 outbreak. The aesthetics industry witnessed significant setbacks due to the COVID-19 pandemic in the first and second quarters of 2020. Lockdowns caused the closure of beauty salons, med spas, dermatological clinics, and retail establishments in various nations because the procedures for cosmetic needs were not medically necessary. Worldwide, hospital management and government representatives asked medical staff to postpone non-emergency appointments. In addition, lockdowns around the world caused numerous retail businesses to close during the first quarter of 2020. Physical store sales were affected as a result.

Request a free sample copy or view report summary: U.S. Post Laser Recovery Products Market Report

U.S. Post Laser Recovery Products Market Report Highlights

• Based on product, cream segment dominated the market in 2022 owing to the higher recommendation of sunscreen and moisturizer for skin recovery, which is the major factor for segment dominance. As per the aesthetician using ceramide creams helps to restore the skin barrier that gets weakened after the laser treatments and also helps in skin regeneration for the skin to heal faster.
• Based on distribution channel, offline channel is dominating the market in 2022. This is due to the fact that a large number of patients still opt for offline distribution of post-laser recovery products as they believe in assessing comfort and finding the best fit for their clinical needs. However, the online segment is likely to have a significant growth rate during the forecast period.
• Key market players include; NeoGenesis, CALECIM Clinic, LA CLINICA, Synergie Skin, RAI Aesthetics, Bynacht, Koru Pharma, Elixir Cosmeceuticals, OxygenCeuticals, Gio Pelle, and Others

Access Press Release@ https://www.grandviewresearch.com/press-release/us-post-laser-recovery-products-market-analysis

U.S. Post Laser Recovery Products Market Segmentation

Grand View Research has segmented the U.S. post-laser recovery products market on the basis of product type, and distribution channel:

U.S. Post Laser Recovery Products Type Outlook (Revenue, USD Million, 2018 - 2030)

• Cream
• Gel
• Serum
• Others

U.S. Post Laser Recovery Products Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online
• Offline

List of Key Players of the U.S. Post Laser Recovery Products Market

• NeoGenesis
• CALECIM Clinic
• LA CLINICA
• Synergie Skin
• RAI Aesthetics
• Bynacht
• Koru Pharma
• Elixir Cosmeceuticals
• OxygenCeuticals
• Gio Pelle

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Japan CDMO Market Witness Excellent Revenue Growth During 2024-2030: Grand View Research Inc

 Japan CDMO Market Growth & Trends

The Japan CDMO market is expected to reach USD 19.49 billion by 2030 and is projected to register a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for biopharmaceuticals, a high burden of diseases, and the rising geriatric population are some of the key growth drivers. Growing investments by various Contract Development and Manufacturing Organizations (CDMOs) for facility and service expansion are likely to boost the market over the forecast period.

In addition, increasing pharmaceutical R&D investments are driving the market growth. As pharmaceutical companies invest more in R&D, they may seek external expertise and resources to accelerate drug development processes. CDMOs provide specialized services in drug development, manufacturing, and testing, making them valuable partners for pharmaceutical companies looking to outsource certain aspects of their R&D activities. Several players are investing in the R&D activities of pharmaceuticals. For instance, in March 2022, WuXi AppTec launched Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) technology to accelerate the production of adeno-associated viruses for drugs in cell and gene therapy.

The increase in outsourcing services by pharmaceutical companies in the pharmaceutical industry has profoundly impacted the Japan market.The trend of outsourcing activities in the pharmaceutical domain is rising as companies find value in acquiring additional competencies essential for successful drug development & commercialization. Besides providing extended expertise & assisting in improved cash flow management, outsourcing brings significant manufacturing advantages, including reducing investment risks.

Notably, regulatory authorities in Japan have accelerated approval for regenerative medical and gene therapy products. For instance, the adoption of the Pharmaceuticals and Medical Devices Act (PMD Act), 21st Century Cures Act, and PRIME (Priority Medicines) Initiative has helped the country improve access to regenerative medicines. Such initiatives by regulatory agencies are expected to improve the demand for the development and manufacturing of regenerative medicines in the country.

Request a free sample copy or view report summary: Japan Contract Development And Manufacturing Organization Market Report

Japan CDMO Market Report Highlights

• The active pharmaceutical ingredient (API) segment dominated the market with a share of 81.2% in 2023. The segment growth is driven by competitive drug development and growing demand for end-to-end Contract Development & Manufacturing Organization (CDMO) services. In addition, advancements in API manufacturing, growth of the biopharmaceutical sector, and the increasing geriatric population are some of the key factors propelling segment growth
• Based on workflow, the commercial segment held the largest market share in 2023, attributed to robust demand for pharmaceutical products, such as biosimilar medications, generic medications, and regenerative therapies. This is where commercial CDMOs may help by providing knowledge, saving time, and being cost-effective.
• Based on application, the oncology segment dominated the test type market in 2023 with a revenue share of 35.3%, owing to the high cancer burden in the country. Approval of regenerative products and virotherapy for cancer treatment can further support market growth and the segment is further driven by increasing number of cancer cases globally. In addition, increasing pharmaceutical R&D investments, patent expirations, and demand for oncology drugs & biologic innovations are the factors driving the oncology segment growth

Access Press Release@ https://www.grandviewresearch.com/press-release/japan-contract-development-manufacturing-organization-market-analysis

Japan CDMO Market Segmentation

Grand View Research has segmented the Japan CDMO market based on product, workflow, and application: 

Japan CDMO Product Type Outlook (Revenue, USD Million, 2018 - 2030)

• API
  • Type
    • Traditional Active Pharmaceutical Ingredient (Traditional API)
    • Highly Potent Active Pharmaceutical Ingredient (HP-API)
    • Antibody Drug Conjugate (ADC)
    • Others
  • Synthesis
    • Synthetic
      • Solid
      • Liquid
    • Biotech
  • Drug
    • Innovative
    • Generic
  • Manufacturing
    • Continuous manufacturing
    • Batch manufacturing
  • Drug Product
    • Oral solid Dose
    • Semi-Solid Dose
    • Liquid Dose
    • Others

Japan CDMO Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical
• Commercial

Japan CDMO Application  Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology
• Hormonal
• Glaucoma
• Cardiovascular Diseases
• Diabetes
• Others

List of Key Players in the Japan CDMO Market

• Lonza
• Thermo Fisher Scientific, Inc.
• Recipharm AB
• Laboratory Corporation of America Holdings (LabCorp)
• Catalent, Inc.
• WuXi AppTec, Inc.
• Samsung Biologics
• FUJIFILM Corporation
• Sumitomo Chemical Company, Limited
• CMIC HOLDINGS Co., LTD.
• CordenPharma International
• Cambrex Corporation
• Bushu Pharmaceuticals Ltd.
• Nipro Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Lip Augmentation Market to Incur Meteoric Growth During 2023 to 2030: Grand View Research Inc.

 Lip Augmentation Market Growth & Trends

The global lip augmentation market size is expected to reach USD 11.61 billion by 2030, growing at a CAGR of 7.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. There is increasing demand for cosmetic procedures due to the growing popularity of lip enhancements among both men and women. Today, full and plump lips are considered a desirable aesthetic feature, and individuals seek lip augmentation procedures to achieve the desired look. Moreover, the influence of social media platforms and celebrity culture has further fueled the demand for lip enhancements as people strive to emulate the lip aesthetics of their favorite influencers and celebrities.

This trend has created a lucrative market for lip augmentation products and services, including injectable fillers and surgical procedures, contributing to the growth of the overall market. Apart from the above factors, another driving factor in the market is the advancements in technology and techniques. Innovations in injectable fillers and surgical procedures have made lip augmentation more accessible, safer, and with better outcomes. The availability of a wide range of injectable options, such as hyaluronic acid-based fillers, allows individuals to choose the type of augmentation that best suits their needs and preferences.

Moreover, the minimally invasive nature of these procedures, with shorter recovery times and fewer risks compared to traditional surgeries, has made lip augmentation an attractive option for individuals seeking immediate results with minimal downtime. Overall, the combination of social trends and technological advancements is propelling the growth of the market for lip augmentation, and this trend is expected to continue in the coming years.

Request a free sample copy or view report summary: Lip Augmentation Market Report

Lip Augmentation Market Report Highlights

• Based on type, the temporary augmentation segment accounted for the largest share of 56.22% in 2022 and is expected to witness the fastest growth over the forecast period. It offers people to try different looks without permanent alterations allowing individuals to experiment and align with their aesthetic goals
• In terms of product, the hyaluronic acid fillers segment is expected to grow at the fastest CAGR of around 9.8% during the forecast period. This growth can be attributed to the rising demand for non-surgical cosmetic procedures. Hyaluronic acid fillers are popular as they offer fuller and more defined lips through quick and convenient procedures
• In 2022, the North America region dominated the market for lip augmentation with the growing demand for aesthetic procedures. The desire for enhanced facial features, particularly fuller lips, is a key driver of this market's growth. The impact of social media has significantly popularized plump lips through influencers

Access Press Release@ https://www.grandviewresearch.com/press-release/global-lip-augmentation-market

Lip Augmentation Market Segmentation

Grand View Research has segmented the global lip augmentation market based on type, product, and region:

Lip Augmentation Type Outlook (Revenue, USD Million, 2018 - 2030)

• Temporary
• Permanent
  • Lip Implants
  • Fat Grafting
  • Fillers
  • Lip Advancement
  • Others

Lip Augmentation Product Outlook (Revenue, USD Million, 2018 - 2030)

• Hyaluronic Acid Fillers
• Poly-L-lactic Acid Fillers
• Fat Injection/Lipoinjection
• Lip Collagen
• Others

Lip Augmentation Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Lip Augmentation Market

• Allergan
• Galderma Pharmaceuticals S.A
• Merz Pharma Gmbh
• Teoxane Laboratories
• Suneva Medical
• Sinclair Pharma
• Laboratoires Vivacy SAS

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Finance Solutions Market To Hold a High Potential for Growth by 2030: Grand View Research Inc.

 Healthcare Finance Solutions Market Growth & Trends

The global healthcare finance solutions market size is expected to reach USD 216.4 billion by 2030, registering a CAGR of 7.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising demand for ongoing improvements and modifications in various healthcare procedures to enhance the efficiency of various healthcare facilities are the factors driving the industry growth. The need for healthcare services is increasing exponentially as a result of the growing aging population and an increase in cases of chronic diseases. The ability to provide the latest edition of medical equipment is essential for maintaining a high standard of patient care.

As hospitals start utilizing the devices of the growing medical technology industry, the ability to finance and lease equipment is becoming even more crucial. It is a crucial component of enabling hospitals and practices to acquire innovations and, as a result, this would create the demand for healthcare finance solutions to invest more in advanced equipment. Real-time access to medical services and related assistance made possible by digital technology could improve the patient experience. This upgrade would require the installation of equipment designed to handle and manage such tasks. With the advancement of technology and the growing demand for advanced healthcare, the cost of the devices would be a major factor for healthcare providers.

The growth of the industry would be greatly impacted by the cost of such devices.The COVID-19 pandemic had severe economic, logistical, and other effects. However, following the pandemic, the industry is putting efforts to invest in the facilities, which include investments in improved forecasting after the supply chain disruptions & shortages, spending more on personnel and safety precautions, such as infrastructure, personnel, and Personal Protective Equipment (PPE). In addition, investments in cybersecurity & remote workforces and in addressing the health disparities that the pandemic has brought to light, such as promoting greater diversity in clinical trials, would support the industry growth.

Request a free sample copy or view report summary: Healthcare Finance Solutions Market Report

Healthcare Finance Solutions Market Report Highlights

• The decontamination equipment segment accounted for the largest revenue share in 2022
• On the basis of healthcare facility type, The hospital & health systems segment accounted for the largest revenue share in 2022
• The equipment and technology finance segment accounted for the largest revenue share of 45.1% in 2022  and accounted for the maximum revenue share in the same year
• This is due to the fact that technology is changing rapidly and the demand for advanced healthcare increases the cost of the equipment
• North America dominated the market and accounted for the largest revenue share of 38.7% in 2022 due to the increased demand for advanced equipment as the institutions adopt the latest devices

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-finance-solutions-market

Healthcare Finance Solutions Market Segmentation

Grand View Research has segmented the global healthcare finance solutions market on the basis of on equipment type, healthcare facility type, service, and region:

Healthcare Finance Solutions Equipment Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Diagnostic/Imaging Equipment
• Specialist Beds
• Surgical Instruments
• Decontamination Equipment
• IT Equipment

Healthcare Finance Solutions Healthcare Facility Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Hospitals & Health Systems
• Outpatient Imaging Centres
• Outpatient Surgery Centres
• Physician Practices & Outpatient Clinics
• Diagnostic Laboratories
• Urgent Care Clinics
• Skilled Nursing Facilities
• Pharmacies
• Other Healthcare Providers

Healthcare Finance Solutions Service Outlook (Revenue, USD Billion, 2018 - 2030)

• Equipment And Technology Finance
• Working Capital Finance
• Project Finance Solutions
• Corporate Lending

Healthcare Finance Solutions Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East And Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Healthcare Finance Solutions Market

• Koninklijke Philips N.V.
• General Electric Company
• Commerce Bancshares, Inc.
• Siemens Financial Services, Inc.
• Thermo Fisher Scientific, Inc.
• Stryker
• Gemino Healthcare Finance
• Oxford Finance LLC
• TCF Capital Solutions
• CIT Group, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Trial Biorepository & Archiving Solutions Market Soaring Demand Assures Motivated Revenue Share By 2030

 Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends

The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.0 billion by 2030, registering a CAGR of 8.3%, from 2023 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Request a free sample copy or view the report summary: Clinical Trial Biorepository & Archiving Solutions Market Report

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights

• The biorepository services segment dominated the industry in 2022 due to the rise in R&D of advanced therapies, such as personalized medicine, and the requirement of high-quality biorepository practices for the collection, processing, testing, and storage of samples
• In terms of phase, the phase III segment dominated the industry in 2022 while the phase II segment is estimated to register the fastest CAGR from 2023 to 2030
• The clinical products segment held the largest share in 2022 as most clinical trial protocols depend largely on the analysis of biological specimens to meet the study endpoints
• Asia Pacific is anticipated to register the fastest growth rate over the forecast period. The shift of clinical trial sites from Western regions, such as Europe and North America, to Asia Pacific is a major factor driving the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-clinical-trial-biorepository-archiving-solutions-market

Clinical Trial Biorepository & Archiving Solutions Market Segmentation

Grand View Research has segmented the global clinical trial biorepository & archiving solutions market based on service, product, phase, and region:

Clinical Trial Biorepository & Archiving Solutions Service Outlook (Revenue, USD Million, 2018 - 2030)

• Biorepository Services
  • Warehousing & Storage
  • Transportation
  • Sample Processing
  • Others
• Archiving Solution Services
  • Database Indexing and Management
  • Scanning & Destruction

Clinical Trial Biorepository & Archiving Solutions Product Outlook (Revenue, USD Million, 2018 - 2030)

• Preclinical Products
• Clinical Products
  • Human Tissue
  • Organs
  • Stem Cells
  • Other Biospecimens

Clinical Trial Biorepository & Archiving Solutions Phase Outlook (Revenue, USD Million, 2018 - 2030)

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trial Biorepository & Archiving Solutions Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Rest of EU
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Rest of MEA

List of Key Players in the Clinical Trial Biorepository & Archiving Solutions Market

• Azenta U.S., Inc.
• Thermo Fisher Scientific Inc. (Patheon)
• Precision for Medicine, Inc.
• Medpace
• LabCorp Drug Development
• ATCC
• Q2 Solutions
• Labconnect
• Charles River Laboratories
• Cell&Co

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Non-surgical Rhinoplasty Market Booming Trends and Forecast Assessment for the Period 2023 to 2030

 Non-surgical Rhinoplasty Market Growth & Trends

The global non-surgical rhinoplasty market size is expected to reach USD 1.3 billion by 2030, registering a CAGR of 8.1% according to a new report by Grand View Research, Inc. Non-surgical rhinoplasty, also known as liquid rhinoplasty is a non-invasive cosmetic procedure used to alter the shape and define a person’s nose by using injectable fillers such as hyaluronic acid fillers. This method offers immediate results, no downtime, is less invasive, and is inexpensive. All these factors are expected to fuel the growth of the market.

Non-surgical rhinoplasty can be done in case a person has a dorsal bump, asymmetrical shape of the nose, dip in the nose bridge, improve/camouflage deformities, or treat mildly crooked nose. However, this procedure is only carried out to smooth out nasal imperfections and fix minor symmetry issues and cannot treat major nasal defects.

Injectable fillers like HA fillers and CaHa fillers are most commonly used in liquid Rhinoplasty procedures. However, as per Medical News Today, HA injectables are widely preferred and adopted by plastic surgeons and this is because these fillers are biocompatible, have a natural feel, provide a defined shape and complications can be reversed using hyaluronidase injection.

The market witnessed significant setbacks due to the COVID-19 pandemic in the second and third quarters of 2020. However, it is expected to witness a recovery as the demand for non-invasive aesthetic treatments saw significant growth post-pandemic. This is majorly due to increased virtual meets, increased disposable income, high social media impact, and desirability to improve aesthetic appearance. According to the American Society of Plastic Surgeons (ASPS), the pandemic led to an increase in the acceptance of cosmetic procedures

Request a free sample copy or view report summary: Non-surgical Rhinoplasty Market Report

Non-surgical Rhinoplasty Market Report Highlights

• The HA filler segment is projected to dominate the market throughout the forecast period. It is the most preferred and highly adopted filler due to its biocompatibility and aesthetic benefits
• The minor nasal asymmetry application wheelchairs segment is projected to witness rapid growth over the forecast period as slight nasal misalignment due to genetics or minor injuries is expected to be prevalent in the global population
• The MedSpa end-use segment dominated the market owing to comprehensive services offered by such facilities, high accessibility, adoption of advanced products and technology as well as the availability of cost-effective treatments
• North America accounted for the highest revenue share in 2022 due to high awareness about non-invasive aesthetic treatment and the presence of major key players
• Asia Pacific is expected to grow at a CAGR of 8.8% over the forecast period, owing to the rising awareness and adoption of cosmetic treatments in Asian countries

Access Press Release@ https://www.grandviewresearch.com/press-release/global-non-surgical-rhinoplasty-market

Non-surgical Rhinoplasty Market Segmentation

Grand View Research has segmented the global non-surgical rhinoplasty market based on filler type, application, end-use and region:

Non-surgical Rhinoplasty Filler Type Outlook (Revenue, USD Million; 2018 - 2030)

• Hyaluronic Acid Fillers
• CaHa Fillers

Non-surgical Rhinoplasty Application Outlook (Revenue, USD Million; 2018 - 2030)

• Indentations of dorsal hump
• Convex Nose
• Minor Nasal Asymmetry
• Others

Non-surgical Rhinoplasty End Use Outlook (Revenue, USD Million; 2018 - 2030)

• MedSpa
• Hospital/Surgery Center
• HCP-owneded clinic

Non-surgical Rhinoplasty Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List Of Key Players Of Non-surgical Rhinoplasty Market

• SKINovative of Gilbert - Medical Spa
• The London Cosmetic Clinic
• Laser Clinic United Kingdom
• Therapie Clinic
• Toronto Cosmetic Clinic (TCC)
• Canada MedLaser, Inc.
• Skin Vitality Medical Clinic
• True MediSpa
• Nova Aesthetic Clinic
• VIVA Skin Clinic
• Piedmont Plastic Surgery & Dermatology

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Spinal Implants And Devices Market to Reach $19.0 Billion by 2030: Grand View Research Inc.

 Spinal Implants And Devices Market Growth & Trends

The global spinal implants and devices market size is expected to reach USD 19.0 billion by 2030, registering a CAGR of 5.4% from 2024 to 2030, according to a new study by Grand View Research, Inc. The growing incidences of spinal cord injuries (SCIs) is a major factor contributing to market growth. For instance, the Centers for Disease Control and Prevention (CDC) estimates that SCIs cost the country around USD 9.7 billion annually.

According to estimates from the National Spinal Cord Injury Association, around 450,000 people in the U.S. are living with spinal cord injuries (SCIs), and about 17,000 new cases are reported annually. This increase in SCI prevalence has led to a higher demand for spinal implants and devices. The World Health Organization (WHO) states that nearly 90% of SCI incidents are due to traumatic events, though the incidence of non-traumatic SCIs is also on the rise. Additionally, it has been noted that between 20% and 30% of individuals with SCI experience significant levels of depression, which negatively impacts their functional recovery and overall well-being. The challenges faced by SCI patients are often exacerbated by limited access to necessary medical care and rehabilitation services.

Advancements in spine surgery technology are driving the expansion of the market. Carlsmed, for example, has launched Aprevo, a cutting-edge interbody solution that comprehensively addresses adult spinal deformity (ASD) through a digital approach. This innovative system utilizes custom 3D-printed implants designed for each patient based on their unique imaging data. Made of titanium, these Aprevo implants are customizable in various aspects, including coronal and lordotic angles, shape, size, and height. Such customization allows for the creation of tailored treatment plans that meet the precise needs of both patients and surgeons, offering an effective approach to managing ASD.

Moreover, introduction of robotic spine surgery, also referred to as robotic-assisted spine surgery has further propelled the market growth. It is a minimally invasive surgical procedure that involves the use of robotic systems to aid the surgeon during the operation. This innovative technique combines the precision and accuracy of robotic technology with the skills and decision-making capabilities of the surgeon and also works as a 3D imaging system.

Request a free sample copy or view report summary: Spinal Implants And Devices Market Report

Spinal Implants And Devices Market Report Highlights

• Based on product, the spinal fusion devices segment accounted for the revenue share of58.4% in 2023 owing to the technological advancements in spine fusion surgery with or without internal fixation
• Based on technology, spinal fusion and fixation technologies segment accounted for the largest market share in 2023. The growth is attributed to their coverage of a broad range of surgical methods, including both posterior and anterior methods
• Based on surgery type, open surgery segment accounted for the largest revenue share in 2023 owing to their flexibility in addressing complex spinal conditions that may require extensive intervention or correction
• Based on procedure type, laminotomy segment accounted for the largest revenue share in 2023 owing to the need to address specific conditions such as spinal stenosis or narrowing of the spinal canal

Access Press Release@ https://www.grandviewresearch.com/press-release/global-spinal-implants-spinal-devices-market

Spinal Implants And Devices Market Segmentation

Grand View Research has segmented the global spinal implants and devices market based on product, technology, surgery type, procedure type, and region:

Spinal Implants And Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Spinal Fusion Devices
  • Thoracic & Lumbar Fusion Devices
  • Cervical Fusion Devices
• Spinal Biologics
  • Allografts
  • Xenografts
  • DBM
  • BMP
  • Synthetic Bone Grafts
• Vertebral Compression Fracture Treatment Devices
• Non-fusion Devices
• Spinal Bone Growth Stimulators

Spinal Implants And Devices Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Spinal Fusion and Fixation Technologies
• Vertebral Compression Fracture Treatment
  • Vertebroplasty
  • Kyphoplasty/Vertebral Augmentation
• Motion Preservation Technologies

Spinal Implants And Devices Surgery Type Outlook (Revenue, USD Million, 2018 - 2030)

• Open Surgery
• Minimally Invasive Surgery

Spinal Implants And Devices Procedure Type Outlook (Revenue, USD Million, 2018 - 2030)

• Discectomy
• Laminotomy
• Foraminotomy
• Corpectomy
• Facetectomy

Spinal Implants And Devices Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Spinal Implants And Devices Market

• Medtronic
• Johnson & Johnson
• Stryker
• NuVasive
• Zimmer Biomet
• Globus Medical, Inc.
• Alphatec Spine, Inc
• Orthofix Holdings, Inc
• RTI Surgical Holdings
• Ulrich GmbH & Co. KG
• Braun Melsungen AG
• Seaspine Holdings Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.